At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
No interventions +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine: a Protocol of a Multi-center, Prospective, Propensity Score-matched, Cohort Analysis
In Brief
An observational study evaluating No interventions and Not have interventions for Platelet-rich Plasma and Chronic Migraine. Completed, enrolled 200 participants across 1 site.
Detailed Summary
This is a multicenter, prospective, observational, propensity score matching, cohort, and assessor-blinded study designed to compare the effectiveness and safety of lidocaine combined Platelet-rich plasma (PRP) acting on SGB versus lidocaine alone acting on SGB in patients with CM.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPlatelet-rich Plasma, Chronic Migraine
CountriesChina
Timeline
N/ACompletedFinished
20252026
Enrollment StartOct 2024
First PostedOct 2024
Primary CompletionJun 2025
Study CompletionSep 2025
TodayJul 2026
First PostedOct 22, 2024
Enrollment StartOct 20, 2024
Primary CompletionJun 30, 2025
Study CompletionSep 30, 2025
TodayJul 1, 2026
Enrollment to primary: 8 monthsPosted 1.7 years ago
Interventions
No interventionsother
It is a observational study
Not have interventionsother
It is a observational study